AUROPHARMA — Aurobindo Pharma Limited

NSE · AI Signal & Stock Analysis · Bearish

As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for AUROPHARMA is Bearish ↓ (moderate move); technical trend down-trend; trading at ₹1,533.70 (+0.68% today); neutral (RSI 49).

Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.

Key metrics

What's driving the signal

• -Near 52w High; -Strong Down
• RSI is neutral
• Relative volume 0.15× (light)
• 5% below its 52-week high
• 50% above its 52-week low

Frequently asked about AUROPHARMA

What is AkshayaAI's signal for AUROPHARMA today?

As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for AUROPHARMA (Aurobindo Pharma Limited) is Bearish with a moderate move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.

Is AUROPHARMA overbought or oversold right now?

AUROPHARMA's RSI is neutral (RSI 49). A reading above 70 is typically overbought and below 30 oversold.

Where is AUROPHARMA in its 52-week range?

AUROPHARMA is trading about 5% below its 52-week high and 50% above its 52-week low as of Aug 14 2026, 6:50 PM.

What is AUROPHARMA's market capitalisation?

AUROPHARMA's market capitalisation is ₹93,332 Cr as of Aug 14 2026, 6:50 PM.

What sector is AUROPHARMA in?

AUROPHARMA is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.

AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →